Advertisement

Breast Cancer Research and Treatment

, Volume 91, Issue 1, pp 29–34 | Cite as

Effect of perductal paclitaxel exposure on the development of MNU-induced mammary carcinoma in female S–D rats

  • Homa Okugawa
  • Daigo YamamotoEmail author
  • Yoshiko Uemura
  • Noriko Sakaida
  • Akihide Tanano
  • Kanji Tanaka
  • Yasuo Kamiyama
Report

Summary

Background. Breast carcinoma and precancer are thought to start in the lining of the milk duct or lobule.

Methods. At 5weeks of age, rats received a intraperitoneal (ip) injection of MNU for carcinogenesis. After mammary tumors were identified macroscopically using fiberscope, the rats were treated with perductal (pd) or ip injection of paclitaxel tri-weekly. At 36 weeks after MNU injection, tumor burden (No. of >1cm palpable mammary tumors/rat), total number of mammary carcinoma, apoptosis (AI), and microvessel density (MVD) were measured.

Results. The administration of paclitaxel through the duct did not produce any toxic side effect. The tumor burden and total number of mammary carcinoma in the pd paclitaxel-treated group were significantly reduced compared to those seen in the ip paclitaxel-treated group. In addition, in the pd paclitaxel-treated group, AI was also increased and MVD was decreased, compared to those in the ip paclitaxel-treated group.

Conclusion. Local administration of paclitaxel may be useful for treatment of breast cancer.

Keywords

fiberoptic ductoscopy paclitaxel mammary carcinoma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wani, MC, Taylor, HL, Wall, ME, Coggon, P, McPhail, AT 1971Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifoliaJ Am Chem Soc9323252327CrossRefPubMedGoogle Scholar
  2. 2.
    Blajeski, AL, Kottke, TJ, Kaufmann, SH 2001A multistep model for paclitaxel-induced apoptosis in human breast cancer cell linesExp Cell Res270277288CrossRefPubMedGoogle Scholar
  3. 3.
    Mingo-Sion, AM, Marietta, PM, Koller, E, Wolf, DM, Van Den Berg, CL 2004Inhibition of JNK reduces G2/M transit independent of p53, leading to endoreduplication, decreased proliferation, and apoptosis in breast cancer cellsOncogene23596604CrossRefPubMedGoogle Scholar
  4. 4.
    Klauber, N, Parangi, S, Flynn, E, Hamel, E, D’Amato, RJ 1997Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxolCancer Res578186PubMedGoogle Scholar
  5. 5.
    Lau, DH, Xue, L, Young, LJ, Burke, PA, CheungAT: Paclitaxel, (Taxol) 1999an inhibitor of angiogenesis in a highly vascularized transgenic breast cancerCancer Biother Radiopharm143136PubMedCrossRefGoogle Scholar
  6. 6.
    Wang, J, Lou, P, Lesniewski, R, Henkin, J 2003Paclitaxel at ultra low concentrations inhibits angiogenesis without affecting cellular microtubule assemblyAnticancer Drugs141319CrossRefPubMedGoogle Scholar
  7. 7.
    Lennernas, B, Albertsson, P, Damber, JE, Norrby, K 2004Antiangiogenic effect of metronomic paclitaxel treatment in prostate cancer and non-tumor tissue in the same animals: a quantitative studyAPMIS112201209CrossRefPubMedGoogle Scholar
  8. 8.
    Folkman, J 1995Clinical applications of research on angiogenesisN Engl J Med33317571763CrossRefPubMedGoogle Scholar
  9. 9.
    Kerbel, RS 2000Tumor angiogenesis: past, present and the near futureCarcinogenesis21505515CrossRefPubMedGoogle Scholar
  10. 10.
    Rothenberg, ML, Liu, PY, Braly, PS, Wilczynski, SP, Hannigan, EV, Wadler, S, Stuart, G, Jiang, C, Markman, M, Alberts, DS 2003Combined intraperitoneal and intravenous chemotherapy for women with optimally debulked ovarian cancer: results from an intergroup phase II trialJ Clin Oncol2113131319CrossRefPubMedGoogle Scholar
  11. 11.
    Rose, WC 1992Taxol: a review of its preclinical in vivo antitumor activityAnticancer Drugs3311321PubMedGoogle Scholar
  12. 12.
    Kubota, T, Matsuzaki, SW, Hoshiya, Y, Watanabe, M, Kitajima, M, Asanuma, F, Yamada, Y, Koh, JI 1997Antitumor activity of paclitaxel against human breast carcinoma xenografts serially transplanted into nude miceSurg Oncol64115121CrossRefGoogle Scholar
  13. 13.
    Love, SM, Barsky, SH 1996Breast duct endoscopy to study stages of cancerous breast diseaseLancet348997999CrossRefPubMedGoogle Scholar
  14. 14.
    Shen, KW, Wu, J, Lu, JS, Han, QX, Shen, ZZ, Nguyen, M, Shao, ZM, Barsky, SH 2000Fiberoptic ductoscopy for patients with nipple dischargeCancer8915121519CrossRefPubMedGoogle Scholar
  15. 15.
    Yamamoto, D, Shoji, T, Uemura, Y, Kawanishi, H, Nakagawa, H, Haijima, H, Gondo, H, Tanaka, K 2001A utility of ductography and fiberoptic ductoscopy for patients with nipple dischargeBreast Cancer Res Treat70103108CrossRefPubMedGoogle Scholar
  16. 16.
    Yamamoto, D, Ueda, S, Senzaki, H, Shoji, T, Kawanishi, H, Nakagawa, H, Haijima, H, Gondo, H, Tanaka, K 2001New diagnostic approach to intracystic lesions of the breast by fiberoptic ductoscopyAnti Cancer Res2141134116Google Scholar
  17. 17.
    Yamamoto, D, Shoji, T, Senzaki, H, Nakagawa, H, Okugawa, H, Gondo, H, Tanaka, K 2003Detection of chromosomal anuesomy by fluorescence in situ hybridization for patients with nipple dischargeCancer97690694CrossRefPubMedGoogle Scholar
  18. 18.
    Yamamoto, D, Tanaka, A 2004Review of mammary ductoscopy in breast cancerBreast J10295297CrossRefPubMedGoogle Scholar
  19. 19.
    Kubota, T, Matsuzaki, SW, Hoshiya, Y, Watanabe, M, Kitajima, M, Asanuma, F, Yamada, Y, Koh, JI 1997Antitumor activity of paclitaxel against human breast carcinoma xenografts serially transplanted into nude miceJ Surg Oncol64115121CrossRefPubMedGoogle Scholar
  20. 20.
    Yang, J, Nakagawa, H, Tsuta, K, Tsubura, A 2000Influence of perinatal genistein exposure on the development of MNU-induced mammary carcinoma in female Sprague-Dawley ratsCancer Lett149171179CrossRefPubMedGoogle Scholar
  21. 21.
    Nikaido, Y, Yoshizawa, K, Pei, R-J, Yuri, T, Danbara, N, Hatano, T, Tsubura, A 2003Prepubertal zearalenone exposure suppresses N-methyl-N-nitrosourea-induced mammary tumorigenesis but causes severe endocrine disruption in female Sprague-Dawley ratsNutr Cancer47164170CrossRefPubMedGoogle Scholar
  22. 22.
    Zhang, X, Yamashita, M, Uetsuki, H, Kakehi, Y 2002Short-term effects of TNP-470 in combination with cisplatin in the rat model of bladder cancerIn Vivo16293297PubMedGoogle Scholar
  23. 23.
    Ohtsu, T, Sasaki, Y, Tamura, T, Miyata, Y, Nakanomyo, H, Nishiwaki, , Saijo, N 1995Clinical pharmacokinetics and pharmacodynamics of paclitaxel: a 3-hour infusion versus a 24-hour infusionClin Cancer Res1599606PubMedGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  • Homa Okugawa
    • 1
    • 2
  • Daigo Yamamoto
    • 1
    Email author
  • Yoshiko Uemura
    • 2
  • Noriko Sakaida
    • 2
  • Akihide Tanano
    • 1
  • Kanji Tanaka
    • 1
  • Yasuo Kamiyama
    • 1
  1. 1.Department of SurgeryKansai Medical UniversityMoriguchiJapan
  2. 2.Department of Clinical PathologyKansai Medical UniversityMoriguchiJapan

Personalised recommendations